MRNA

MRNA·Healthcare

www.modernatx.com

Moderna, Inc. , a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

$145.55

▼ -$3.32 (-2.23%)Today

Open

$153.00

High

$154.04

Low

$141.52

Volume

15M

$22.2852-Week Range$176.66

Current: $145.55 · Near 52W High

MARKET CAP

$58.1B

P/E (TTM)

—

P/B RATIO

8.6x

ROE

-39.0%

EPS (TTM)▲ 2.1% Rev YoY

$-7.98

DIVIDEND YIELD

N/A

BETA

1.11

Market-correlated

Company Info

Industry

Biotechnology

Country

United States

Leadership

Mr. Stéphane Bancel M.B.A.

Chief Executive Officer

Stock Score

Best Value

5/ 100

Val

Grw

Qly

Value 40%·Growth 35%·Quality 25%

Price History

$145.55▲ $120.72 (486.19%)

Overlays

Oscillators

Generating analysis...

01 / Income Statement

Income Statement

Revenue & Margin Trend

Period	Revenue	OpEx	EBITDA	Net Income	EPS
2022	$18.88B	$4.04B	$9.77B	$8.36B	$20.12
2023	$6.75B▼	$6.30B	$-3.62B	$-4.71B▼	$-12.33
2024	$3.20B▼	$5.68B	$-3.39B	$-3.56B▲	$-9.28
2025	$1.92B▼	$4.13B	$-2.54B	$-2.82B▲	$-7.26

02 / Balance Sheet

Balance Sheet

Cash & Equivalents

$2.60B

Total Debt

$1.30B

Assets Distribution

Current Assets

Non-Current Assets

Liabilities & Equity

Current Liabilities

Non-Current Liabilities

Equity

03 / Cash Flow

Cash Flow

Negative free cash flow of -$2.1B — the company is burning cash.

Operating CF

-$1.9B

Free Cash Flow

-$2.1B

Investing CF

$1.9B

Financing CF

$593M

Cash Flow Mix

Operating Cash-$1.9B

Investing Cash$1.9B

Financing Cash$593M

Net Change$666M

Operating Strength

Despite negative free cash flow, operating cash flow of -$1.9B indicates the core business is generating cash.

Cash Burn Concern

Cash burn rate of $2.1B requires monitoring. The company may need external financing if this persists.

Is the cash flow sustainable?

Negative Free Cash Flow

Negative free cash flow indicates the company is burning cash and may need to raise capital or cut spending.

04 / Financial Ratios

Financial Ratios

Profitability

Gross Margin

54.8%

Gross Profit / Revenue

Operating Margin

-159.9%

Op. Income / Revenue

Net Margin

-146.8%

Net Income / Revenue

ROIC

-28.3%

Return on Invested Capital

Liquidity & Leverage

Current Ratio

3.29x

Current Assets / Current Liab.

Cash Ratio

1.31x

Cash / Current Liab.

Debt-to-Equity

0.15

Total Debt / Equity

Asset Turnover

0.16

Revenue / Total Assets

Returns

ROE

-39.0%

Return on Equity

ROA

-13.3%

Return on Assets

EPS (TTM)

-$7.98

Earnings Per Share

06 / Historical Trends

Historical Trends

Revenue

-53.3% CAGR

Net Income

EPS

Institutional Ownership

Moderate Institutional Support

Top 3 institutional holders control 26.5% of shares, providing a stable foundation of institutional capital.

Retail Influence

Lower institutional concentration means retail sentiment and broader market trends may drive price action more noticeably.

Top Institutional Holders

FMR, LLC12.99%

51.86M shares

Blackrock Inc.7.66%

30.6M shares

Vanguard Capital Management LLC5.81%

23.21M shares

Capital World Investors5.58%

22.28M shares

BAILLIE GIFFORD & CO4.56%

18.21M shares

Top ETFs Holding

Growth Fund of America3.75%

14.98M shares

VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.84%

11.33M shares

VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.29%

9.15M shares

VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.05%

8.19M shares

Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund1.70%

6.79M shares

07 / Market Events

Market Events

Upcoming Earnings

NOV

5THU

DateNov 5, 2026

DayThursday

Revenue Est.$895M

EPS Est.$-1.31

08 / Market Intelligence

Market Intelligence

Analyst Consensus

Consensus (23 Ratings)

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Recent Insider Trades

MOCK JAMES M

Chief Financial Officer

Sale

1,103 shs

KLINGER SHANNON THYME

Officer

Sale

1,103 shs

HOGE STEPHEN

President

Sale

2,048 shs

BANCEL STEPHANE J

Chief Executive Officer

Sale

751,715 shs

Price Targets

Upside to Mean-20.0%

$45$117$170

Low

$45.00

Mean

$116.50

Median

$125.00

High

$170.00

Earnings History

Beat Rate

4/4

Avg Surprise

+28.0%

Period	Est. EPS	Act. EPS	Surprise
2025-09	$-2.18	$-0.51	+76.6%
2025-12	$-2.60	$-2.11	+18.9%
2026-03	$-3.88	$-3.40	+12.4%
2026-06	$-2.06	$-1.97	+4.3%